Drug added to brain surgery aims to stop bleeds from coming back
NCT ID NCT07245264
Summary
This study is testing if adding a common clot-stabilizing medication called tranexamic acid (TXA) to standard surgery can prevent a chronic brain bleed from returning. Adults scheduled for surgery to drain a chronic subdural hematoma will be randomly assigned to receive either surgery alone or surgery plus the medication. The main goal is to see if the added medication reduces the need for a second surgery within 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Post Graduate Institute of Medical Education & Research
RECRUITINGChandigarh, 160012, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.